Oak Ridge Investments LLC Boosts Stake in Intuitive Surgical, Inc. $ISRG

Oak Ridge Investments LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,508 shares of the medical equipment provider’s stock after acquiring an additional 311 shares during the quarter. Oak Ridge Investments LLC’s holdings in Intuitive Surgical were worth $10,057,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of ISRG. Chilton Capital Management LLC boosted its stake in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Elite Financial Inc. purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $26,000. LFA Lugano Financial Advisors SA purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. TD Capital Management LLC boosted its stake in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter worth about $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ISRG has been the topic of several recent analyst reports. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Wednesday. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Fourteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $589.43.

Intuitive Surgical Price Performance

ISRG opened at $429.59 on Friday. The company’s 50 day simple moving average is $458.68 and its two-hundred day simple moving average is $497.91. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a market capitalization of $154.00 billion, a price-to-earnings ratio of 59.91, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the company posted $1.78 EPS. The business’s revenue was up 21.4% on a year-over-year basis. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the sale, the director owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.